BUILDING BRIDGES TO REACH PEOPLE WHO INJECT DRUGS WITH THE GOAL TO ELIMINATE HCV

This exciting grassroots initiative taps into the strengths and resources of communities in inner-city and metropolitan areas to provide effective therapy for hepatitis C virus (HCV)-positive people who inject drugs (PWIDs). Live meetings for small, community-based groups of healthcare professionals will offer medical and addiction-services specialists cutting-edge strategies to collaboratively reach and treat HCV-positive PWIDs. Balancing clinical data with real-world experience and insights, these educational events will give participants the opportunity to interact directly with HCV and harm-reduction experts as well as resources to use and share in the practice setting. Strong local HCV-care networks will help build bridges to HCV-infected PWIDs and allow these high-risk individuals access to the care they need and deserve.

Goals of this educational initiative

Prepare community-based HCV treaters to provide effective therapy for
HCV-positive PWIDs
Increase HCV testing and treatment of PWIDs through proactive risk identification and
referral by addiction-services centers
Educate HCV-care specialists and addiction-services personnel regarding harm-reduction
principles and the prevention of HCV reinfection
Build linkages to HCV-care networks within local/regional systems, drive both high
treatment and high sustained viral response (SVR) rates, and decrease the incidence of
HCV infection/reinfection among PWIDs

"Elimination of HCV is possible, but awareness and referral of people who inject drugs is not enough. To truly make an impact, changes need to happen at the community level."

Stacey Trooskin, MD, PhD

Physician and director of Viral hepatitis program

faculty

philadelphia chairperson

Stacey Trooskin, MD, PhD
Physician and Director of Viral Hepatitis Program
Jonathan Lax Treatment Center
Philadelphia FIGHT
Philadelphia, Pennsylvania

2017 Steering Committee Members

Jody Gilmore, MSN, CRNP
Nurse Practitioner
Coordinator, Viral Hepatitis Program at Penn Presbyterian Medical Center
Philadelphia, Pennsylvania

Alain H. Litwin, MD
Professor, Department of Medicine
Professor, Department of Psychiatry and Behavioral Sciences
Albert Einstein College of Medicine
Bronx, New York

Mark S. Sulkowski, MD
Medical Director, Viral Hepatitis Center
Professor of Medicine
Johns Hopkins Medicine
Baltimore, Maryland

content

Small-Group Training for Community-BASED HCV Treaters

Part 1: Keys to Successful Treatment of HCV in People Who Inject Drugs

Part 2: Anatomy of Addiction

Small-Group Training for Community-Based
Addiction Services Providers

Resources

Meetings

Philadelphia FIGHT

Part 1: Keys to Successful Treatment of HCV in People Who Inject Drugs

date: November 8, 2017 – 12:00 PM – 1:00 PM
Location: 3rd Floor TEACH Classroom
1233 Locust Street, Philadelphia, PA 19107

Temple University

Part 1: Keys to Successful Treatment of HCV in People Who Inject Drugs

date: November 9, 2017 – 12:00 PM – 1:00 PM
Location: MERB 105 Room - First Floor
3500 N Broad St, Philadelphia, PA 19140

Kirkbride Center

SMALL-GROUP TRAINING FOR COMMUNITY-BASED ADDICTION SERVICES PROVIDERS

date: DECEMBER 11, 2017 – 12:00 PM – 1:00 PM
Location: DOWNSTAIRS CONFERENCE ROOM
111 NORTH 49TH STREET, PHILADELPHIA, PA 19139

Temple University

Part 2: Anatomy of Addiction

date: November 16, 2017 – 12:00 PM – 1:00 PM
Location: MERB 105 Room - First Floor
3500 N Broad St, Philadelphia, PA 19140

Philadelphia FIGHT

Part 2: Anatomy of Addiction

date: November 22, 2017 – 12:00 PM – 1:00 PM
Location: 3rd Floor TEACH Classroom
1233 Locust Street, Philadelphia, PA 19107

Meetings anticipated in Baltimore and the Bronx in 2018—Stay Tuned!

want to become part of bridge hcv?

become a participating member

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form :(

attend a meeting near you

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form :(

Collaborators

Continuing Medical Education (CME) INFORMATION

Target Audience

This educational initiative is intended for the following target audiences:

Medical specialists currently treating HCV

Addiction-services specialists: Opioid substitution therapy/monitoring programs; needle-exchange programs; other addiction-services programs

Educational Objectives: HCV Treaters

Educational Objectives: Addiction-Services Specialists

This activity is jointly provided by Purdue University College of Pharmacy and Integritas Communications.